News Formal

Many Generic Drugs Haven’t Hit Market, Hindering Cost-Control Efforts

  • 📰 WSJ
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

United States News News

United States United States Latest News,United States United States Headlines

To curb high drug costs, the U.S. has approved record numbers of generic drugs in recent years. But only a fraction have gone on sale.

Record numbers of generic drugs for cancer, heart ailments and other conditions have received U.S. approval in recent years, raising hopes that the new competition would reduce high drug costs. But many of the lower-price medicines haven’t hit the market, a Wall Street Journal review found.

The result: Many patients are forced to take high-price medicines, and a widely touted remedy for reining in drug costs has failed to live up to its promise.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Double-whammy of Brexit and election hits UK housing market - surveyThe number of properties put up for sale in Britain has fallen by the most in an...
Source: Reuters - 🏆 2. / 97 Read more »